Best Cancer Specialist in Mumbai-Dendritic Cell Therapy for Breast Cancer
Cancer starts forming when the human body's immunity fails. This is when the WBC (white blood cells) in the body cannot restrain the cancer cell. When the white blood cells fail to function, the foreign body cells multiply erratically at a very fast pace. These irregularly breeding abnormal cells are known as cancer cells. Hence cancer arises when the white blood cells do not have the capacity to fight against the cancer cells. Also they are not capable to recognize the foreign cells.
Dendritic cells are potent stimulators of antigen specific immune responses, including anti tumor responses. DC (dendritic cells) represents unique antigen producing cells capable of sensitizing T cells to both new and recall antigens. In fact these cells are the most potent antigen producing cells.
The treatment known as dendritic Cell Therapy is a cell based immunotherapy which emerging in India to treat cancer. Dendritic Cell Therapy (DCT) is available as DENVAX in India. DENVAX is a dendritic cell based treatment which is suitable for various types of solid cancers in various stages of treatment. DC therapy can be given post the conventional treatment which is usually radiation, chemotherapy and surgery. It prevents relapse and reduces the progression of the cancer cells. In high risk patients who face relapse, administering DENVAX gives better results.
DENVAX is an autologous treatment which involves the patients' own mononuclear cells transformed into cancer specific dendritic cells. Designed to be specific, DENVAX focuses on killing only the cancer cells and does not harm the healthy cells. It is a safe and effective treatment which helps in restoring the body's immune system.
It is important to understand the reason of cancer relapse? A cancer relapse usually happens as during the treatment to remove cancer, often some cancer cells tend to remain behind. These cancer cells remain dormant for a period of time but eventually they continue to multiply resulting in recurrence or relapse.
Cancer treatment methods like surgical resection, chemotherapy and radiation are usually ineffective in controlling the micro metastasis. These are single tumor cells or a group of cells left behind by solid cancer and the same has disseminated in various parts of the body. DENVAX works effectively and destroys the disseminated cancer cells. It works towards preventing its development by slowing the spread of cancer and increase mortality.
DCT can be given alone, however it is much more effective when it is combined with chemotherapy where is reduces the side effects of chemotherapy and helps fight against cancer cells. Given separately past the conventional treatment is a better option. Once the conventional treatment like radiation, chemotherapy or surgery is over, the DC vaccine can be administered. A single infusion takes between 30 minutes to 60 minutes to be transmitted. As a side effect, the patient may have fever for 24 to 48 hours.
Benefits of DCT:
Improvement in quality of life has been observed along with an increase in life duration from 3 to 9 months.
The survival time period of the patient is usually free from diseases
Progression of disease is retarded. At times past the conventional treatment there is residue. The progression of the disease is reduced with immunotherapy.
It has no side effect as this is a not a product manufactured externally. The patient's body gives blood and other fluids which are used for the immunization.
Prevents side effects like vomiting and hair loss. Chemotherapy works on cell reduction and consistent chemotherapy sessions end up killing the normal cells along with the cancer cells. Till the cells take time to recuperate, a patient has to bear the side effects of vomiting and hair loss. DCT prevents these side effects
Pain free butterfly infusion.
Dendritic Cell Therapy is available for all solid tumors in breast, bone, brain, bladder, colon, head, neck and pancreas. In other words it is available for any tumor in an organ except hematological malignancies where it is not yet available. The treatment has proven beneficial in lymphomas but administered in leukemia. Also as of now DCT is used in advanced stages of cancer and not the early stages. High risk patients benefit the most from immunotherapy. The practice of DCT has been yet to catch up in many other places in India as practitioners are skeptical about stem cell therapy in general.
more information click here
Dendritic cells are potent stimulators of antigen specific immune responses, including anti tumor responses. DC (dendritic cells) represents unique antigen producing cells capable of sensitizing T cells to both new and recall antigens. In fact these cells are the most potent antigen producing cells.
The treatment known as dendritic Cell Therapy is a cell based immunotherapy which emerging in India to treat cancer. Dendritic Cell Therapy (DCT) is available as DENVAX in India. DENVAX is a dendritic cell based treatment which is suitable for various types of solid cancers in various stages of treatment. DC therapy can be given post the conventional treatment which is usually radiation, chemotherapy and surgery. It prevents relapse and reduces the progression of the cancer cells. In high risk patients who face relapse, administering DENVAX gives better results.
DENVAX is an autologous treatment which involves the patients' own mononuclear cells transformed into cancer specific dendritic cells. Designed to be specific, DENVAX focuses on killing only the cancer cells and does not harm the healthy cells. It is a safe and effective treatment which helps in restoring the body's immune system.
It is important to understand the reason of cancer relapse? A cancer relapse usually happens as during the treatment to remove cancer, often some cancer cells tend to remain behind. These cancer cells remain dormant for a period of time but eventually they continue to multiply resulting in recurrence or relapse.
Cancer treatment methods like surgical resection, chemotherapy and radiation are usually ineffective in controlling the micro metastasis. These are single tumor cells or a group of cells left behind by solid cancer and the same has disseminated in various parts of the body. DENVAX works effectively and destroys the disseminated cancer cells. It works towards preventing its development by slowing the spread of cancer and increase mortality.
DCT can be given alone, however it is much more effective when it is combined with chemotherapy where is reduces the side effects of chemotherapy and helps fight against cancer cells. Given separately past the conventional treatment is a better option. Once the conventional treatment like radiation, chemotherapy or surgery is over, the DC vaccine can be administered. A single infusion takes between 30 minutes to 60 minutes to be transmitted. As a side effect, the patient may have fever for 24 to 48 hours.
Benefits of DCT:
Improvement in quality of life has been observed along with an increase in life duration from 3 to 9 months.
The survival time period of the patient is usually free from diseases
Progression of disease is retarded. At times past the conventional treatment there is residue. The progression of the disease is reduced with immunotherapy.
It has no side effect as this is a not a product manufactured externally. The patient's body gives blood and other fluids which are used for the immunization.
Prevents side effects like vomiting and hair loss. Chemotherapy works on cell reduction and consistent chemotherapy sessions end up killing the normal cells along with the cancer cells. Till the cells take time to recuperate, a patient has to bear the side effects of vomiting and hair loss. DCT prevents these side effects
Pain free butterfly infusion.
Dendritic Cell Therapy is available for all solid tumors in breast, bone, brain, bladder, colon, head, neck and pancreas. In other words it is available for any tumor in an organ except hematological malignancies where it is not yet available. The treatment has proven beneficial in lymphomas but administered in leukemia. Also as of now DCT is used in advanced stages of cancer and not the early stages. High risk patients benefit the most from immunotherapy. The practice of DCT has been yet to catch up in many other places in India as practitioners are skeptical about stem cell therapy in general.
more information click here
Source...